Pacira BioSciences, Inc. (PCRX)
Debt-to-assets ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total assets | US$ in thousands | 1,553,520 | 1,521,690 | 1,646,820 | 1,583,320 | 1,574,390 | 1,534,460 | 1,542,380 | 1,523,420 | 1,681,200 | 1,734,360 | 1,733,990 | 1,891,480 | 2,075,350 | 1,356,000 | 1,325,830 | 1,287,550 | 1,274,510 | 1,220,270 | 866,111 | 821,379 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $1,553,520K
= 0.00
The debt-to-assets ratio of Pacira BioSciences, Inc. has consistently remained at 0.00 from March 31, 2020, to December 31, 2024. This implies that the company has not taken on any debt as a proportion of its total assets during this period. A debt-to-assets ratio of 0.00 indicates that the company's assets are entirely funded by equity capital rather than debt financing. This could suggest a conservative financial approach by the company, as it does not rely on external borrowing to finance its operations and investments. It also reflects a strong financial position and stability, as there is no financial leverage present in the company's capital structure.
Peer comparison
Dec 31, 2024